Key result
Beta-adrenergic stimulation reprograms cardiac macrophages from lipid metabolism in hypertrophy to ion channels in HF.
Why the study?
Chronic beta-adrenergic signaling drives pathological hypertrophy and heart failure involving macrophages, but the temporal transcriptomic evolution of cardiac macrophages during this remodeling is not characterized.
Does chronic beta-adrenergic stimulation with isoproterenol alter the transcriptomic and lipidomic mapping of cardiac macrophages during the progression to heart failure?
Does chronic beta-adrenergic stimulation with isoproterenol alter the transcriptomic and lipidomic mapping of cardiac macrophages during the progression to heart failure?
This preclinical mapping highlights dynamic genetic and metabolic changes in cardiac macrophages, providing potential novel markers and therapeutic targets for early hypertrophy and heart failure.
Characterizes time-dependent macrophage profiles in adrenergic remodeling; leaves open translation to human HF and therapeutic targeting.
Sympathetic nervous system overdrive with chronic release of catecholamines is the most important neurohormonal mechanism activated to maintain cardiac output in response to heart stress. Beta-adrenergic signaling behaves first as a compensatory pathway improving cardiac contractility and maladaptive remodeling but becomes dysfunctional leading to pathological hypertrophy and heart failure (HF). Cardiac remodeling is a complex inflammatory syndrome where macrophages play a determinant role. This study aimed at characterizing the temporal transcriptomic evolution of cardiac macrophages in mice subjected to beta-adrenergic-stimulation using RNA sequencing. Owing to a comprehensive bibliographic analysis and complementary lipidomic experiments, this study deciphers typical gene profiles in early compensated hypertrophy (ECH) versus late dilated remodeling related to HF. We uncover cardiac hypertrophy- and proliferation-related transcription programs typical of ECH or HF macrophages and identify lipid metabolism-associated and Na+ or K+ channel-related genes as markers of ECH and HF macrophages, respectively. In addition, our results substantiate the key time-dependent role of inflammatory, metabolic, and functional gene regulation in macrophages during beta-adrenergic dependent remodeling. This study provides important and novel knowledge to better understand the prevalent key role of resident macrophages in response to chronically activated beta-adrenergic signaling, an effective diagnostic and therapeutic target in failing hearts.
No takes yet. Share an insight, caveat, or question.
Nadaud et al. (2022) studied Isoproterenol-induced cardiac remodeling (Early Compensated Hypertrophy and Heart Failure). Isoproterenol vs. Vehicle was evaluated on Temporal transcriptomic evolution of cardiac macrophages using RNA sequencing (p=<0.05). Chronic beta-adrenergic stimulation with isoproterenol induced distinct transcriptomic and lipidomic profiles in cardiac macrophages, highlighting lipid metabolism genes in early hypertrophy and ion channel genes in late heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: